Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report: Ixekizumab (Taltz). CADTH.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Ixekizumab (Taltz). Ottawa (ON): CADTH, 2017.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Ixekizumab (Taltz). CADTH, 2017.
Warning: These citations may not always be 100% accurate.